Drug Profile
Chlortalidone/valsartan
Alternative Names: Valsartan/chlortalidoneLatest Information Update: 23 Feb 2016
Price :
$50
*
At a glance
- Originator Farma de Colombia
- Class Antihypertensives; Branched-chain amino acids; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Thiazide-like diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 23 Feb 2016 No recent reports on development identified - Phase-III for Hypertension in Ecuador and Colombia (PO)
- 01 Apr 2013 Phase-III clinical trials in Hypertension in Colombia (PO)
- 01 Apr 2013 Phase-III clinical trials in Hypertension in Ecuador (PO)